AstraZeneca’s Covid jab has been approved for use in the European Union as a booster or third jab, the British drug giant confirmed on Monday.
The European Medicines Agency (EMA), the European Union’s drug monitoring body, released the news on Thursday.
“AstraZeneca’s COVID-19 vaccine, Vaxzevria, has been approved by the EMA as the third dose booster for adults,” the company said in a statement.
“Healthcare professionals can now use Vaxzevria as a third dose booster for those who were previously given the initial vaccine schedule for Vaxzevria or an EU-approved mRNA Covid-19 vaccine.”
The EMA concludes that “there is ample evidence of increased immunity after the third dose booster with Vaxgevria”, it added.
AstraZeneca, along with Oxford University, quickly built its successful COVID-19 JAB during the epidemic.
The group announced last month that sales of Vauxhallus had quadrupled in the first quarter to $ 1.15 billion, despite a 40 percent drop in Europe where the epidemic was controlled by vaccinations.
However, AstraZeneca warned in April that Covid’s revenues, including Vauxhallus, would decline this year as the health crisis eased.
(Except for the title, this story was not edited by NDTV staff and was published from a syndicated feed.)